CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...

Sun Pharmaceutical Industries Ltd. closed 8.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Experts agree that overexposure to sunlight increases the risk of skin cancer, premature aging of the skin, development of ...

Private equity activity in healthcare remained resilient with 42 deals worth $562 million, just shy of last quarter’s $603 ...

On Tuesday, Fujifilm Diosynth announced a 10-year agreement worth more than $3 billion to make medicines for the New York drugmaker Regeneron in the Triangle. Regeneron is the facility’s third major ...

India's pharma and healthcare sector demonstrates resilient investor interest, marked by a 34% year-on-year increase in deal ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

As trade tensions between the US and China escalate, a small-cap ASX biotech could become a strategic gateway for bringing Asia’s next wave of cellular immunotherapies into lucrative Western markets.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences ...

After falling 17 per cent since the start of the year to its March lows, the stock of the country's largest pharmaceutical ...

Pharma Stocks; The Indian pharma market experienced a robust growth of 9.3% year-on-year in March 2025, with key players like ...